QUOTED. 9 July 2019. Vivek Reddy.
A new analysis suggests that Boston Scientific Corp.'s Watchman left-atrial appendage closure device is a cost-effective alternative to warfarin or other anticoagulant drugs for patients with atrial fibrillation. See what Vivek Reddy of the Mount Sinai Hospital said about it here.
"As you get further away from the procedure, the risk-benefit goes more and more in favor of appendage closure." – Vivek Reddy, researcher, Mount Sinai Hospital
Click here for a free trial of Medtech Insight